Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes

Abstract Rheumatoid arthritis (RA), a chronic inflammatory joint disease causing permanent disability, involves exosomes, nanosized mammalian extracellular particles. Circular RNA (circRNA) serves as a biomarker in RA blood samples. This research screened differentially expressed circRNAs in RA pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Guoqing Li, Hongyi Chen, Jiacheng Shen, Yimin Ding, Jingqiong Chen, Yongbin Zhang, Mingrui Tang, Nan Xu, Yuxuan Fang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-025-05494-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571469451755520
author Guoqing Li
Hongyi Chen
Jiacheng Shen
Yimin Ding
Jingqiong Chen
Yongbin Zhang
Mingrui Tang
Nan Xu
Yuxuan Fang
author_facet Guoqing Li
Hongyi Chen
Jiacheng Shen
Yimin Ding
Jingqiong Chen
Yongbin Zhang
Mingrui Tang
Nan Xu
Yuxuan Fang
author_sort Guoqing Li
collection DOAJ
description Abstract Rheumatoid arthritis (RA), a chronic inflammatory joint disease causing permanent disability, involves exosomes, nanosized mammalian extracellular particles. Circular RNA (circRNA) serves as a biomarker in RA blood samples. This research screened differentially expressed circRNAs in RA patient plasma exosomes for novel diagnostic biomarkers. In this study, samples of RA patients with insufficient response to methotrexate (MTX-IR), combined use of tumor necrosis factor inhibitors (TNFi) were followed up for half a year, and 56 circRNA samples of self-test data were stratified into training, testing, and external validation cohorts according to whether American College of Rheumatology 20% improvement criteria (ACR20) was achieved. A diagnostic xgboost model was developed using common hub genes identified by random forest and least absolute shrinkage and selection operator (LASSO), with intersection genes derived from overlapping machine learning-selected genes. Diagnostic performance evaluated via receiver operating characteristic (ROC) curves using pROC for area under the curve (AUC). Optimal LASSO model with 4 circRNAs determined, with AUC > 0.6 for key genes. The model validation performed well on the test set, but not significantly on the validation set. Then, circRNA screening was performed in combination with clinical data, and cross-validation identified hsa-circ0002715, hsa-circ0001946, hsa-circ0000836, and rheumatoid factor (RF) as key genes, among which hsa-circ0002715 and hsa-circ0001946 were emphasized as key markers on the training set. In addition, the morphology and size of exosomes and the expression of CD9 and CD81 verified the successful extraction of exosomes. The qPCR analysis of plasma exosomes in TNFi patients found that the expression of hsa-circ0002715 was higher than that in patients who didn’t reach ACR20, and the expression of hsa-circ0001946 was lower than that in patients who didn’t reach ACR20. The above studies suggested that hsa-circ0002715 and hsa-circ0001946 may become markers for predicting MTX-IR RA patients and TNFi precision treatment.
format Article
id doaj-art-acf0b12b4b7843eda6ef45859aeaa9e1
institution Kabale University
issn 1749-799X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj-art-acf0b12b4b7843eda6ef45859aeaa9e12025-02-02T12:34:10ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2025-01-0120111310.1186/s13018-025-05494-9Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomesGuoqing Li0Hongyi Chen1Jiacheng Shen2Yimin Ding3Jingqiong Chen4Yongbin Zhang5Mingrui Tang6Nan Xu7Yuxuan Fang8Department of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityDepartment of Rheumatology and Immunology, Affiliated Hospital of Yangzhou University, Yangzhou UniversityAbstract Rheumatoid arthritis (RA), a chronic inflammatory joint disease causing permanent disability, involves exosomes, nanosized mammalian extracellular particles. Circular RNA (circRNA) serves as a biomarker in RA blood samples. This research screened differentially expressed circRNAs in RA patient plasma exosomes for novel diagnostic biomarkers. In this study, samples of RA patients with insufficient response to methotrexate (MTX-IR), combined use of tumor necrosis factor inhibitors (TNFi) were followed up for half a year, and 56 circRNA samples of self-test data were stratified into training, testing, and external validation cohorts according to whether American College of Rheumatology 20% improvement criteria (ACR20) was achieved. A diagnostic xgboost model was developed using common hub genes identified by random forest and least absolute shrinkage and selection operator (LASSO), with intersection genes derived from overlapping machine learning-selected genes. Diagnostic performance evaluated via receiver operating characteristic (ROC) curves using pROC for area under the curve (AUC). Optimal LASSO model with 4 circRNAs determined, with AUC > 0.6 for key genes. The model validation performed well on the test set, but not significantly on the validation set. Then, circRNA screening was performed in combination with clinical data, and cross-validation identified hsa-circ0002715, hsa-circ0001946, hsa-circ0000836, and rheumatoid factor (RF) as key genes, among which hsa-circ0002715 and hsa-circ0001946 were emphasized as key markers on the training set. In addition, the morphology and size of exosomes and the expression of CD9 and CD81 verified the successful extraction of exosomes. The qPCR analysis of plasma exosomes in TNFi patients found that the expression of hsa-circ0002715 was higher than that in patients who didn’t reach ACR20, and the expression of hsa-circ0001946 was lower than that in patients who didn’t reach ACR20. The above studies suggested that hsa-circ0002715 and hsa-circ0001946 may become markers for predicting MTX-IR RA patients and TNFi precision treatment.https://doi.org/10.1186/s13018-025-05494-9Rheumatoid arthritisTumor necrosis factor inhibitorscircRNAPlasma exosomesMachine learning
spellingShingle Guoqing Li
Hongyi Chen
Jiacheng Shen
Yimin Ding
Jingqiong Chen
Yongbin Zhang
Mingrui Tang
Nan Xu
Yuxuan Fang
Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
Journal of Orthopaedic Surgery and Research
Rheumatoid arthritis
Tumor necrosis factor inhibitors
circRNA
Plasma exosomes
Machine learning
title Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
title_full Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
title_fullStr Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
title_full_unstemmed Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
title_short Unveiling new therapeutic horizons in rheumatoid arthritis: an In-depth exploration of circular RNAs derived from plasma exosomes
title_sort unveiling new therapeutic horizons in rheumatoid arthritis an in depth exploration of circular rnas derived from plasma exosomes
topic Rheumatoid arthritis
Tumor necrosis factor inhibitors
circRNA
Plasma exosomes
Machine learning
url https://doi.org/10.1186/s13018-025-05494-9
work_keys_str_mv AT guoqingli unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT hongyichen unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT jiachengshen unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT yiminding unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT jingqiongchen unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT yongbinzhang unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT mingruitang unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT nanxu unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes
AT yuxuanfang unveilingnewtherapeutichorizonsinrheumatoidarthritisanindepthexplorationofcircularrnasderivedfromplasmaexosomes